Sibling Capital
6
49M
2
0.67
2
- Stages of investment
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Rancho Santa Fe. The venture was found in North America in United States.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Sibling Capital, startups are often financed by OrbiMed, Sprout Group, New Leaf Venture Partners. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Limulus Venture Partners, Vivo Capital. In the next rounds fund is usually obtained by OrbiMed, Limulus Venture Partners, Vivo Capital.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2018. This Sibling Capital works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2012. The fund is constantly included in less than 2 deals per year.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Relypsa, Tricida.
The fund was created by Sandra Coufal. The overall number of key employees were 1.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 0
- Exits
- 2
- Follow on index
- 0.67
- Investments by industry
- Health Care (6)
- Pharmaceutical (4)
- Medical (4)
- Biopharma (2)
- Biotechnology (2)
- Investments by region
-
- United States (6)
- Peak activity year
- 2012
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 750M
- Group Appearance index
- 1.00
- Avg. company exit year
- 9
- Avg. multiplicator
- 2.24
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Relypsa | 14 Aug 2012 | Biotechnology, Health Care, Biopharma | Late Stage Venture | 80M | United States, California, Redwood City |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.